Bloomage Biotechnology (China) Performance
| 688363 Stock | 48.35 1.05 2.13% |
The firm shows a Beta (market volatility) of 0.98, which signifies possible diversification benefits within a given portfolio. Bloomage Biotechnology returns are very sensitive to returns on the market. As the market goes up or down, Bloomage Biotechnology is expected to follow. At this point, Bloomage Biotechnology has a negative expected return of -0.31%. Please make sure to confirm Bloomage Biotechnology's standard deviation, total risk alpha, maximum drawdown, as well as the relationship between the jensen alpha and treynor ratio , to decide if Bloomage Biotechnology performance from the past will be repeated at some point in the near future.
Risk-Adjusted Performance
0 of 100
Weak | Strong |
Very Weak
Over the last 90 days Bloomage Biotechnology Corp has generated negative risk-adjusted returns adding no value to investors with long positions. Despite weak performance in the last few months, the Stock's basic indicators remain somewhat strong which may send shares a bit higher in March 2025. The current disturbance may also be a sign of long term up-swing for the company investors. ...more
| Begin Period Cash Flow | 1.2 B |
Bloomage |
Bloomage Biotechnology Relative Risk vs. Return Landscape
If you would invest 5,936 in Bloomage Biotechnology Corp on November 2, 2024 and sell it today you would lose (1,101) from holding Bloomage Biotechnology Corp or give up 18.55% of portfolio value over 90 days. Bloomage Biotechnology Corp is generating negative expected returns and assumes 2.2011% volatility on return distribution over the 90 days horizon. Simply put, 19% of stocks are less volatile than Bloomage, and 99% of all equity instruments are likely to generate higher returns than the company over the next 90 trading days. Expected Return |
| Risk |
Bloomage Biotechnology Market Risk Analysis
Today, many novice investors tend to focus exclusively on investment returns with little concern for Bloomage Biotechnology's investment risk. Standard deviation is the most common way to measure market volatility of stocks, such as Bloomage Biotechnology Corp, and traders can use it to determine the average amount a Bloomage Biotechnology's price has deviated from the expected return over a period of time. It is calculated by determining the expected price for the established period and then subtracting this figure from each price point. The differences are then squared, summed, and averaged to produce the variance.
Sharpe Ratio = -0.1418
| Best Portfolio | Best Equity | |||
| Good Returns | ||||
| Average Returns | ||||
| Small Returns | ||||
| Cash | Small Risk | Average Risk | High Risk | Huge Risk |
| Negative Returns | 688363 |
Estimated Market Risk
| 2.2 actual daily | 19 81% of assets are more volatile |
Expected Return
| -0.31 actual daily | 0 Most of other assets have higher returns |
Risk-Adjusted Return
| -0.14 actual daily | 0 Most of other assets perform better |
Based on monthly moving average Bloomage Biotechnology is not performing at its full potential. However, if added to a well diversified portfolio the total return can be enhanced and market risk can be reduced. You can increase risk-adjusted return of Bloomage Biotechnology by adding Bloomage Biotechnology to a well-diversified portfolio.
Bloomage Biotechnology Fundamentals Growth
Bloomage Stock prices reflect investors' perceptions of the future prospects and financial health of Bloomage Biotechnology, and Bloomage Biotechnology fundamentals are critical determinants of its market performance. Overall, investors pay close attention to revenue and earnings growth, profit margins, and debt levels. These fundamentals can have a significant impact on Bloomage Stock performance.
| Return On Equity | 0.062 | ||||
| Return On Asset | 0.0319 | ||||
| Profit Margin | 0.08 % | ||||
| Operating Margin | 0.06 % | ||||
| Current Valuation | 23.05 B | ||||
| Shares Outstanding | 481.68 M | ||||
| Price To Book | 3.32 X | ||||
| Price To Sales | 4.07 X | ||||
| Revenue | 6.08 B | ||||
| EBITDA | 664.83 M | ||||
| Total Debt | 153.13 M | ||||
| Book Value Per Share | 14.67 X | ||||
| Cash Flow From Operations | 699.65 M | ||||
| Earnings Per Share | 0.91 X | ||||
| Total Asset | 8.47 B | ||||
| Retained Earnings | 2.45 B | ||||
About Bloomage Biotechnology Performance
By analyzing Bloomage Biotechnology's fundamental ratios, stakeholders can gain valuable insights into Bloomage Biotechnology's financial health, operational efficiency, and overall profitability, helping them make informed investment and management decisions. For instance, if Bloomage Biotechnology has a high ROA and ROE, it suggests that the company is efficiently using its assets and equity to generate substantial profits, making it an attractive investment. Conversely, if Bloomage Biotechnology has a low ROA and ROE, it may indicate underlying issues in asset and equity management, signaling a need for operational improvements.
Things to note about Bloomage Biotechnology performance evaluation
Checking the ongoing alerts about Bloomage Biotechnology for important developments is a great way to find new opportunities for your next move. Stock alerts and notifications screener for Bloomage Biotechnology help investors to be notified of important events, changes in technical or fundamental conditions, and significant headlines that can affect investment decisions.| Bloomage Biotechnology generated a negative expected return over the last 90 days | |
| About 60.0% of the company shares are owned by insiders or employees |
- Analyzing Bloomage Biotechnology's financial statements, including its income statement, balance sheet, and cash flow statement, helps in understanding its overall financial health and growth potential.
- Getting a closer look at valuation ratios like price-to-earnings (P/E) ratio, price-to-sales (P/S) ratio, and price-to-book (P/B) ratio help in understanding whether Bloomage Biotechnology's stock is overvalued or undervalued compared to its peers.
- Examining Bloomage Biotechnology's industry or sector and how it is performing can give you an idea of its growth potential and how it is positioned relative to its competitors.
- Evaluating Bloomage Biotechnology's management team can have a significant impact on its success or failure. Reviewing the track record and experience of Bloomage Biotechnology's management team can help you assess the Company's leadership.
- Pay attention to analyst opinions and ratings of Bloomage Biotechnology's stock. These opinions can provide insight into Bloomage Biotechnology's potential for growth and whether the stock is currently undervalued or overvalued.
Complementary Tools for Bloomage Stock analysis
When running Bloomage Biotechnology's price analysis, check to measure Bloomage Biotechnology's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Bloomage Biotechnology is operating at the current time. Most of Bloomage Biotechnology's value examination focuses on studying past and present price action to predict the probability of Bloomage Biotechnology's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Bloomage Biotechnology's price. Additionally, you may evaluate how the addition of Bloomage Biotechnology to your portfolios can decrease your overall portfolio volatility.
| Odds Of Bankruptcy Get analysis of equity chance of financial distress in the next 2 years | |
| Piotroski F Score Get Piotroski F Score based on the binary analysis strategy of nine different fundamentals |